Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

16 June 2006

Conversion From Cyclosporine-Based Immunosuppression to Tacrolimus/ Mycophenolate Mofetil in Patients with Refractory and Ongoing Acute Renal Allograft Rejection

Maria Boratynska, Miroslaw Banasik, Dariusz Patrzalek, Marian Klinger

Ann Transplant 2006; 11(2): 51-56 :: ID: 496987


Aim of the study: was to examine the influence of conversion from cyclosporine-based therapy to tacrolimus/mycophenolate mofetil (MMF) on renal graft survival in patients with refractory rejection and on the recurrence of rejection in patients converted at the time of the first episode of rejection. Patients and methods: A total of 64 renal graft recipients were converted to tacrolimus/MMF: 30 patients (Group I) in whom acute allograft rejection was not resolved after anti-rejection therapy; 34 patients (Group II) with first acute rejection, in whom tacrolimus/MMF was an adjunctive therapy to corticosteroid treatment. Results: In Group I, ten patients failed to recover graft function. Another 10 patients lost their grafts within 2 years after conversion. Two-year graft survival was 30%. Gastro-intestinal complications or leucopenia necessitated immunosuppressants dose reduction or interruption in 50% of the patients. In Group II, recurrence of acute rejection episode occurred in 12% of patients. Ten patients (30%) developed chronic rejection within 2 years after conversion. One and two year kidney graft survival was 97% and 93.6% respectively. Conclusions: Conversion to tacrolimus/MMF in patients with refractory rejection improved or stabilized renal function, but this effect was shortlasting. Intolerance of immunosuppressive drugs contributed greatly to the treatment inefficacy. Conversion to tacrolimus/MMF during the first acute rejection resulted in low risk of recurrent rejection. Nevertheless, progression to chronic graft nephropathy was observed.

Keywords: renal transplantation, Refractory Rejection, Cyclosporine, Tacrolimus, acute rejection, Mycophenolate Mofetil

Add Comment 0 Comments

In Press

Original article  

Engraftment Syndrome in Autologous Hematopoietic Stem Cell Transplant Patients: Incidence, Associated Risk ...

Ann Transplant In Press; DOI: 10.12659/AOT.944043  

Original article  

Comparative Study of Acute Kidney Injury in Liver Transplantation: Donation after Circulatory Death versus ...

Ann Transplant In Press; DOI: 10.12659/AOT.944077  

Original article  

Abnormal Liver Biopsies of Donor Grafts in Pediatric Liver Transplantation: How Do They Fare?

Ann Transplant In Press; DOI: 10.12659/AOT.944245  

Original article  

Kidney After Lung Transplants or Combined Kidney–Lung Transplantation: A Single-Center Retrospective Cohort...

Ann Transplant In Press; DOI: 10.12659/AOT.944049  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,433

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   9,299

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   8,875

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   6,675

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358